Biotech Investors & VC Firms in Amsterdam
15 firms in this list, with a median first check of $550K. 6 of them lead rounds. Generated from verified public data and updated continuously.
Rockstart
AmsterdamPre-Seed–Series B$114.4K – $2.3M
29 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Innovation Industries
AmsterdamSeed–Late Stage$2.2M – $54M
25 people
DOMiNO Ventures
AmsterdamSeed–Series B$220K – $1.1M
30 people
ScaleX Ventures
AmsterdamSeed–Series A$216K – $2.2M
15 people
Forbion
NaardenPre-Seed–Late Stage
24 people
Inkef
AmsterdamSeed–Growth
14 people
ACT Venture Partners
AmsterdamPre-Seed–Seed$550K – $1.6M
17 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
Positron Ventures
AmsterdamPre-Seed–Series A
8 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
8 people
Curie Capital
AmsterdamSeed–Series A
8 people
UvA Ventures Holding
AmsterdamPre-Seed–Seed
Schouten Investments
AmsterdamSeries B–Late Stage
2 people
NATO Innovation Fund
AmsterdamSeed–Series B$16.2M
3 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.












































